ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

GTBP GT Biopharma Inc

3.50
0.23 (7.03%)
May 17 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 27.44M24.17M21.07M16.74M20.09M18.14M16.15M14.11M
Total Current Assets 27.19M23.95M20.87M16.56M19.94M18.02M16.05M14.06M
Cash and Equivalents 7.29M5.36M2.47M5.67M2.05M2.77M2.65M1.08M
Total Non-Current Assets 246k223k199k174k149k123k96k53k
Total Liabilities 9.65M8.73M5.12M5M7.03M6.38M6.14M6.63M
Total Current Liabilities 9.5M8.61M5.03M4.94M4.08M4.84M5.09M6.63M
Total Non-Current Liabilities 147k120k92k64k2.96M1.54M1.05M0
Common Equity 33k32k34k34k38k42k43k2k
Retained Earnings -659.02M-662M-668.88M-674.47M-674.7M-676.69M-679.1M-682.07M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 25k254.37M25.4M396k5.66M32.17M16.74M14.11M
Total Current Assets 21k576k90k274k5.66M32.17M16.56M14.06M
Cash and Equivalents 19k576k60k28k5.3M8.97M5.67M1.08M
Total Non-Current Assets -18.92M251.69M11.37M-19.31M-29.43M21.91M11.73M7.48M
Total Liabilities 18.95M2.68M14.03M19.71M35.09M10.26M5M6.63M
Total Current Liabilities 18.95M2.68M14.03M19.71M35.09M10.26M4.94M6.63M
Total Non-Current Liabilities 00000064k0
Total Equity -18.92M251.69M11.37M-19.31M-29.43M21.91M11.73M7.48M
Common Equity 34k52k53k73k55k33k34k2k
Retained Earnings -124.65M-267.9M-528.69M-567.33M-595.63M-653.58M-674.47M-682.07M